Aims and scope

AAPS Open, the flagship open access journal of the American Association of Pharmaceutical Scientists, provides a global forum for the rapid publication of original research and discussion that demonstrates applications of scientific concepts and techniques across the breadth of the pharmaceutical sciences.

Fully peer-reviewed, AAPS Open welcomes reports from experimental or theoretical studies during the entire course of development of a drug candidate, for both synthetic drugs as well as biopharmaceutical products including vaccines, cell and gene therapeutics, and other new modalities such as nucleotide-based therapeutics.

The journal’s interest in drug development research includes - but is not limited to - drug discovery, translational research, preclinical studies, pharmacokinetic and pharmacodynamics studies, formulation design and stability testing, drug delivery and drug administration including all aspects around combination products, analytical assay development and validation, modeling and simulation approaches, mechanistic studies, drug substance and drug product manufacturing, clinical evaluation, as well as regulatory topics or post-launch activities.

AAPS Open specifically welcomes white papers, commentaries, and perspectives from experts in their field, as well as meeting reports, and review or brief review articles. For reports of primary research, a high degree of innovation is required.